| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
inositol polyphosphate-4-phosphatase type II B | 0.573 | 0.577 | 0.55 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.460 | None | 1.000 | 0 | 0 | 1995 | 2017 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
forkhead box A1 | 0.522 | 0.731 | 0.22 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
fibroblast growth factor 4 | 0.588 | 0.577 | 0.14 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 1996 | 1996 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.400 | None | 0.917 | 0 | 0 | 1990 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.410 | None | < 0.001 | 0 | 0 | 2019 | 2019 | ||||||||
|
fibroblast growth factor 3 | 0.505 | 0.808 | 9.3E-05 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.330 | None | 1.000 | 0 | 0 | 2004 | 2008 |